Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02869334 · ClinicalTrials.gov registry record · NA
Remediation of Auditory Recognition in Schizophrenia With tDCS
A NA study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02869334: Completed NA study, sponsored by New York State Psychiatric Institute.
NCT02869334 is a NA study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02869334, a NA study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether transcranial direct current stimulation (tDCS), when combined with different forms of computer based training, improves the ability to discriminate small differences between sounds in people diagnosed with schizophrenia or schizoaffective disorder.
Primary Outcome
Ability to match tones following brief delay
Interventions
- DEVICE Active Transcranial direct current stimulation (tDCS)
- DEVICE Sham Transcranial direct current stimulation (tDCS)
- BEHAVIORAL Auditory Remediation
- BEHAVIORAL Control computer activities
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-06 |
| Est. Completion | 2020-01-31 |
| Phase | NA |
What the finished NCT02869334 record still lists
NCT02869334 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which Active Transcranial direct current stimulation (tDCS) is the first listed.
NCT02869334 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02869334 about?
NCT02869334 is a clinical study titled "Remediation of Auditory Recognition in Schizophrenia With tDCS". The purpose of this study is to determine whether transcranial direct current stimulation (tDCS), when combined with different forms of computer based training, improves the ability to discriminate small differences between sounds in people diagnosed with schizophrenia or schizoaffective disorder.
What is the current status of trial NCT02869334?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2016-06. Estimated completion is 2020-01-31.
What interventions are being tested in trial NCT02869334?
The interventions under investigation include: Active Transcranial direct current stimulation (tDCS) (DEVICE), Sham Transcranial direct current stimulation (tDCS) (DEVICE), Auditory Remediation (BEHAVIORAL), Control computer activities (BEHAVIORAL).
Who is sponsoring clinical trial NCT02869334?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02869334's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia